EOquin

· Spectrum Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for EOquin, covering 2012-06-14 to 2012-06-14. Get the full timeline:

Most recent: Clinical Trial Update: Phase II Trial of EOquin in High-risk Superficial Bladder Cancer [Phase 2]